A Proposal for Data Registry system for Urologic Cancers in Iran
Urology Journal,
Vol. 19 No. 03 (2022),
,
Page 238-240
https://doi.org/10.22037/uj.v18i.6790
Abstract
Purpose: Data registries are organized systems that facilitate collection, storage, and analysis of data related to a specific disease in a defined population. Here we introduce a data registry system which was designed to cover the four most common urologic cancers (prostate, bladder, renal and testis).
Materials and methods: All contributing centers can enter data into the system after logging in with their unique usernames and passwords. In this system, the information of each individual patient will be entered in several structured forms covering various steps of management of the patients.
Results: Our proposed registry is an interactive, web-based database designed to collect complete data of patients with common urological cancers. We devised a council that functions as the central committee that will initiate, supervise, and monitor all steps of the projects including data collection, data audit, as well as data analysis and publication. To facilitate manuscript publication, the system will provide assistance and support throughout all the steps of statistical analysis and manuscript preparation.
Conclusion: This proposed registry can have a national target and is designed to provide evidence-based information that could support strategic planning and national multi-centric studies.
- Disease-specific outcomes; Epidemiology; Population-based; Prospective registries; urologic malignancies
How to Cite
References
2. Mohammadi G, Akbari ME, Mehrabi Y, Ghanbari Motlagh A. Quality Assessment of the National Cancer Registry in Iran: Completeness and Validity. Int J Cancer Manag. 2016;9(6):e8479.
3. White MC, Babcock F, Hayes NS, Mariotto AB, Wong FL, Kohler BA, et al. The history and use of cancer registry data by public health cancer control programs in the United States. 2017;123 Suppl 24(Suppl 24):4969-76.
4. Dahm P, N'Dow J, Holmberg L, Hamdy F. The future of randomised controlled trials in urology. European urology. 2014;66(1):1-3.
5. Gandaglia G, Bray F, Cooperberg MR, Karnes RJ, Leveridge MJ, Moretti K, et al. Prostate Cancer Registries: Current Status and Future Directions. European urology. 2016;69(6):998-1012.
6. Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC public health. 2015;15:997.
7. Farhood B, Geraily G, Alizadeh A. Incidence and Mortality of Various Cancers in Iran and Compare to Other Countries: A Review Article. Iranian journal of public health. 2018;47(3):309-16.
8. Tannock IF. Improving Treatment for Advanced Prostate Cancer. New England Journal of Medicine. 2019;381(2):176-7.
9. Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. European urology. 2020;77(4):508-47.
10. Graham J, Heng DYC, Brugarolas J, Vaishampayan U. Personalized Management of Advanced Kidney Cancer. American Society of Clinical Oncology educational book American Society of Clinical Oncology Annual Meeting. 2018;38:330-41.
11. Rafiemanesh H, Rajaei-Behbahani N, Khani Y, Hosseini S, Pournamdar Z, Mohammadian-Hafshejani A, et al. Incidence Trend and Epidemiology of Common Cancers in the Center of Iran. Global journal of health science. 2015;8(3):146-55.
12. van Rees Vellinga S, de la Rosette J. The CROES data management system: a glimpse behind the scenes. Journal of endourology. 2011;25(1):1-5.
13. Manyalich M, Gómez MP, Reis DL. International Registry in Organ Donation and Transplantation (IRODAT) - 2016 Worldwide Data. Transplantation. 2018;102:S800.
- Abstract Viewed: 0 times
- 6790/pdf Downloaded: 0 times